Department of Microbiology, University of Manitoba, Winnipeg, MB, R3T2N2, Canada.
Department of Microbiology, University of Manitoba, Winnipeg, MB, R3T2N2, Canada; National Institute for Bioprocessing Research & Training (NIBRT), Fosters Avenue, Dublin, A94 X099, Ireland.
J Biotechnol. 2021 Jun 10;333:49-62. doi: 10.1016/j.jbiotec.2021.04.005. Epub 2021 Apr 24.
The control of glycosylation profiles is essential to the consistent manufacture of therapeutic monoclonal antibodies that may be produced from a variety of cell lines including CHO and NS0. Of particular concern is the potential for generating non-human epitopes such as N-glycolylneuraminic acid (Neu5Gc) and Galα1-3 Gal that may be immunogenic. We have looked at the effects of a commonly used media supplements of manganese, galactose and uridine (MGU) on Mab production from CHO and NS0 cells in enhancing galactosylation and sialylation as well as the generation of these non-human glycan epitopes. In the absence of the MGU supplement, the humanized IgG1 antibody (Hu1D10) produced from NS0 cells showed a low level of mono- and di-sialylated structures (SI:0.09) of which 75 % of sialic acid was Neu5Gc. The chimeric human-llama Mab (EG2-hFc) produced from CHO cells showed an equally low level of sialylation (SI: 0.12) but the Neu5Gc content of sialic acid was negligible (<3%). Combinations of the MGU supplements added to the production cultures resulted in a substantial increase in the galactosylation of both Mabs (up to GI:0.78 in Hu1D10 and 0.81 in EG2-hFc). However, the effects on sialylation differed between the two Mabs. We observed a slight increase in sialylation of the EG2-hFc Mab by a combination of MG but it appeared that one of the components (uridine) was inhibitory to sialylation. On the other hand, MG or MGU increased sialylation of Hu1D10 substantially (SI:0.72) with an increase that could be attributed predominantly to the formation of Neu5Ac rather than Neu5Gc. The increased level of galactosylation observed with MG or MGU was attributed to an activation of the galactosyl transferase enzymes through enhanced intracellular levels of UDP-Gal and the availability of Mn as an enzymic co-factor. However, this effect not only increased the desirable beta 1-4 Gal linkage to GlcNAc but unfortunately in NS0 cells increased the formation of Galα1-3 Gal which was shown to increase x3 in the presence of combinations of the MGU supplements. Supplementation of media with fetal bovine serum (FBS) increased the availability of free Neu5Ac which resulted in a significant increase in the sialylation of Hu1D10 from NS0 cells. This also resulted in a significant decrease in the proportion of Neu5Gc in the measured sialic acid from the Mab.
糖基化谱的控制对于治疗性单克隆抗体的一致制造至关重要,这些抗体可能由多种细胞系生产,包括 CHO 和 NS0。特别令人关注的是产生潜在免疫原性的非人类表位,例如 N-糖基化唾液酸(Neu5Gc)和 Galα1-3Gal。我们研究了常用的培养基补充物锰、半乳糖和尿苷(MGU)对 CHO 和 NS0 细胞生产单克隆抗体的影响,以增强半乳糖基化和唾液酸化以及这些非人类糖基化表位的产生。在没有 MGU 补充物的情况下,从 NS0 细胞产生的人源化 IgG1 抗体(Hu1D10)显示出低水平的单和二唾液酸化结构(SI:0.09),其中 75%的唾液酸为 Neu5Gc。从 CHO 细胞产生的嵌合人-美洲驼单克隆抗体(EG2-hFc)显示出同样低水平的唾液酸化(SI:0.12),但唾液酸中的 Neu5Gc 含量可以忽略不计(<3%)。将 MGU 补充物添加到生产培养物中会导致两种单克隆抗体的半乳糖基化显著增加(Hu1D10 增加到 GI:0.78,EG2-hFc 增加到 0.81)。然而,两种单克隆抗体的唾液酸化效果不同。我们观察到 EG2-hFc 单克隆抗体的唾液酸化略有增加,这是由于 MG 的组合作用,但似乎其中一种成分(尿苷)对唾液酸化具有抑制作用。另一方面,MG 或 MGU 大大增加了 Hu1D10 的唾液酸化(SI:0.72),这种增加可以主要归因于 Neu5Ac 的形成,而不是 Neu5Gc。观察到 MG 或 MGU 增加半乳糖基化是由于细胞内 UDP-Gal 水平升高和 Mn 作为酶辅助因子的可用性激活了半乳糖基转移酶。然而,这种效应不仅增加了 GlcNAc 上理想的β1-4Gal 连接,而且不幸的是,在 NS0 细胞中增加了 Galα1-3Gal 的形成,在 MGU 补充物的组合存在下,Galα1-3Gal 的形成增加了 3 倍。用胎牛血清(FBS)补充培养基增加了游离 Neu5Ac 的可用性,从而显著增加了 NS0 细胞来源的 Hu1D10 的唾液酸化。这也导致了测量的单克隆抗体中的 Neu5Gc 在唾液酸中的比例显著降低。